X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1932) 1932
Publication (371) 371
Dissertation (52) 52
Book Chapter (22) 22
Conference Proceeding (16) 16
Book Review (10) 10
Book / eBook (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pp2a (1535) 1535
index medicus (993) 993
humans (810) 810
phosphorylation (706) 706
animals (701) 701
protein phosphatase 2a (560) 560
biochemistry & molecular biology (548) 548
cell biology (545) 545
protein phosphatase 2 - metabolism (541) 541
phosphatases (364) 364
mice (322) 322
apoptosis (307) 307
proteins (294) 294
oncology (281) 281
cancer (275) 275
signal transduction (271) 271
phosphatase (245) 245
expression (242) 242
activation (240) 240
protein phosphatase 2 - genetics (222) 222
cell line, tumor (219) 219
phosphoprotein phosphatases - metabolism (219) 219
okadaic acid (200) 200
protein phosphatase (188) 188
male (185) 185
protein phosphatase 2 (176) 176
article (171) 171
female (170) 170
cell cycle (150) 150
neurosciences (149) 149
kinases (144) 144
rats (144) 144
dephosphorylation (141) 141
kinase (141) 141
protein phosphatase 2 - antagonists & inhibitors (141) 141
catalytic subunit (140) 140
cell line (136) 136
inhibition (135) 135
cells (133) 133
enzyme inhibitors - pharmacology (124) 124
research (123) 123
biophysics (122) 122
protein binding (121) 121
identification (119) 119
cells, cultured (116) 116
phosphoprotein phosphatase (115) 115
gene expression (113) 113
pp1 (111) 111
growth (105) 105
mitosis (105) 105
akt (104) 104
environment and public health (104) 104
molecular sequence data (103) 103
amino acid sequence (102) 102
biology (102) 102
alzheimer's disease (99) 99
okadaic acid - pharmacology (98) 98
phosphorylation - drug effects (96) 96
enzymes and coenzymes (95) 95
physiological aspects (95) 95
binding (93) 93
proto-oncogene proteins c-akt - metabolism (93) 93
signal transduction - drug effects (93) 93
macromolecular substances (92) 92
genetics & heredity (90) 90
phosphoprotein phosphatases - antagonists & inhibitors (90) 90
regulatory subunit (90) 90
cip2a (89) 89
mutation (89) 89
tumor-suppressor (89) 89
phosphatase 2a (88) 88
health aspects (86) 86
cell proliferation (85) 85
research article (85) 85
blotting, western (84) 84
protein-serine-threonine kinases - metabolism (84) 84
enzymes (83) 83
brain (81) 81
phosphoprotein phosphatases - genetics (81) 81
pharmacology & pharmacy (79) 79
apoptosis - drug effects (78) 78
genetic aspects (77) 77
pathway (77) 77
hela cells (75) 75
saccharomyces-cerevisiae (75) 75
enzyme activation (74) 74
oxidative stress (74) 74
in-vivo (73) 73
tau (73) 73
tumor-suppressor pp2a (73) 73
set (71) 71
alzheimers-disease (70) 70
c-myc (70) 70
protein kinases (70) 70
methylation (68) 68
cell proliferation - drug effects (67) 67
serine (67) 67
multidisciplinary sciences (64) 64
protein (64) 64
transcription factors - metabolism (64) 64
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1958) 1958
Chinese (20) 20
Korean (7) 7
Japanese (5) 5
French (4) 4
Spanish (2) 2
German (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FEBS Letters, ISSN 0014-5793, 07/2012, Volume 586, Issue 16, pp. 2522 - 2528
► GSK-3β can inhibit PP2A by increasing the inhibitory L309-demethylation. ► GSK-3β can regulate PME-1 and PPMT1 mRNA and protein levels. ► GSK-3 could... 
Protein phosphatase methylesterase | Demethylation | Protein phosphatase-2A | Leucine carboxyl methyltransferase 1 | Alzheimer’s disease | Glycogen synthase kinase-3β | PPMT | dmL309-PP2AC | PME-1 | C57BL/6J | GSK-3β | CREB | inhibitor-2 of PP2A | glycogen synthase kinase-3β | PP2AC | protein phosphatase-2A | leucine carboxyl methyltransferase 1 | small interference RNA | Alzheimer's disease | PP2AB | cAMP response element binding protein | protein phosphatase methylesterase | wortmannin | pY307 | C57 | demethylation of PP2A catalytic subunit at leucine-309 | I2 PP2A | PP2A | siRNA | enhanced chemiluminescence | PP2A regulatory subunit | phosphorylation of PP2A catalytic subunit at tyrosine-307 | PP2A catalytic subunit | ECL | Sprague–Dawley | SB216763 | ALZHEIMER-DISEASE BRAIN | CATALYTIC SUBUNIT | METHYLTRANSFERASE | TYROSINE PHOSPHORYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | NEUROFIBRILLARY PATHOLOGY | TAU | CELL BIOLOGY | BOVINE BRAIN | METHYL ESTERIFICATION | BIOPHYSICS | RAT-BRAIN | Glycogen synthase kinase-3 beta | Protein Phosphatase 2 - chemistry | Humans | Enzyme Inhibitors - pharmacology | Glycogen Synthase Kinase 3 beta | Glycogen Synthase Kinase 3 - metabolism | Leucine - chemistry | Dose-Response Relationship, Drug | Gene Expression Regulation, Enzymologic | DNA Methylation | Alzheimer Disease - metabolism | HEK293 Cells | Cell Line, Tumor | Lentivirus - genetics | Protein O-Methyltransferase - metabolism | Catalysis | Methylation | Carboxylic Ester Hydrolases - metabolism
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2014, Volume 4
Reversible protein phosphorylation plays a crucial role in regulating cell signaling. In normal cells, phosphoregulation is tightly controlled by a network of... 
Inhibitor | PP2A | PP2A activating drugs | Subunit | Tumor suppressor reactivation therapy | tumor suppressor reactivation therapy | subunit | inhibitor | PP2A Activating Drug
Journal Article
Nature Immunology, ISSN 1529-2908, 05/2016, Volume 17, Issue 5, pp. 478 - 479
Regulatory T cells must limit activation of the metabolic checkpoint kinase mTOR to maintain their identity. The lipid ceramide serves a unique role in this... 
PHOSPHATASE PP2A | KINASE | IMMUNOLOGY
Journal Article
Cancer Letters, ISSN 0304-3835, 2013, Volume 335, Issue 1, pp. 9 - 18
Journal Article
Oncogene, ISSN 0950-9232, 06/2011, Volume 30, Issue 22, pp. 2504 - 2513
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2010, Volume 19, Issue 4, pp. 1221 - 1229
Journal Article
Cell Cycle, ISSN 1538-4101, 05/2014, Volume 13, Issue 9, pp. 1400 - 1412
Entry and progression through mitosis has traditionally been linked directly to the activity of cyclin-dependent kinase 1 (Cdk1). In this study we utilized low... 
Cdk1 | cyclin B1 | PP2A | SAC | mitosis | RO3306 | Cyclin | Mitosis | Report
Journal Article
Oncotarget, ISSN 1949-2553, 2019, Volume 10, Issue 21, pp. 2008 - 2009
Journal Article
CANCER RESEARCH, ISSN 0008-5472, 08/2019, Volume 79, Issue 16, pp. 4009 - 4010
Critically important to reducing uterine cancer mortality is the development of more effective therapy for aggressive endometrial cancers, including uterine... 
PP2A | ONCOLOGY | LANDSCAPE | UTERINE
Journal Article
FASEB Journal, ISSN 0892-6638, 12/2018, Volume 32, Issue 12, pp. 6456 - 6468
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 01/2019, Volume 116, Issue 3, pp. 982 - 987
Phosphatase PP2A expression levels are positively correlated to the clinical severity of systemic lupus erythematosus (SLE) and IL17A cytokine overproduction,... 
EAE | TGFβ | SMAD2/SMAD3 | PP2A | TH17
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 09/2019, Volume 201, pp. 181 - 201
Protein phosphatase 2A (PP2A) is a highly complex heterotrimeric enzyme that catalyzes the selective removal of phosphate groups from protein serine and... 
Multiple sclerosis | Inflammation | Alzheimer’s disease | Neurodegeneration | Protein phosphatase 2A | Cancer | Alzheimer's disease | CHRONIC MYELOGENOUS LEUKEMIA | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | FACTOR-ALPHA PRODUCTION | DENDRITIC CELL-MIGRATION | SPHINGOSINE 1-PHOSPHATE RECEPTOR-1 | FIBROBLAST-LIKE SYNOVIOCYTES | CHRONIC LYMPHOCYTIC-LEUKEMIA | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | IMPROVES COGNITIVE PERFORMANCE | NF-KAPPA-B | Phosphates | Enzymes | Phosphatases | Dendritic cells | Amino acids | B cells | Metastasis | Biological response modifiers | Transforming growth factors | Sphingosine | Interferon beta | Health aspects | Mitogens | Protein kinases | Protein binding | TGFβ, transforming growth factor β | TRIF, Toll | S1P, sphingosine-1-phosphate | TRAM, Toll | BBB, blood-brain barrier | TTP, tristetraprolin | NOT, carbon catabolite repressor 4 | never on TATA-less | PRR, pattern recognition receptor | CCR4 | NFT, neurofibrillary tangles | MyD88, myeloid differentiation factor 88 | STRN, striatin | S1PR, S1P receptor | TNF, tumor necrosis factor | TAB, TAK1 binding protein | PP2A, protein phosphatase 2A | CIP2A, cancerous inhibitor of PP2A | IKK, IκBα kinase | TAK1, transforming growth factor β-activated kinase | NF-κB, nuclear factor κ enhancer of activated B cells | IL, interleukin | LCMT-1, leucine carboxymethyl transferase 1 | HEAT, Huntingtin - Elongation factor - A subunit of PP2A - Target of rapamycin domain | TIRAP, Toll | MAPK, mitogen-activated protein kinase | PAMP, pathogen-associated molecular pattern | PME-1, protein phosphatase methylesterase 1 | SphK, sphingosine kinase | IκBα, α inhibitor of NF-κB | TLR, Toll-like receptor | DC, dendritic cell | PAD, PP2A-activating drug | AD, Alzheimer’s disease | interleukin 1 receptor domain-containing adaptor molecule | JNK, cJun N-terminal kinase | interleukin 1 receptor domain-containing adaptor protein | AP-1, activator protein 1 | MK2, MAPK-activated kinase 2 | LUBAC, linear ubiquitin chain assembly complex | ROS, reactive oxygen species | UVB, ultraviolet B | interleukin 1 receptor domain-containing adaptor inducing interferon β | MKK, MAPK kinase | TRAF, TNF receptor interacting factor | MS, multiple sclerosis | CNS, central nervous system | IRF, interferon-regulatory factor | EAE, experimental autoimmune encephalopathy
Journal Article
CELL RESEARCH, ISSN 1001-0602, 09/2019, Volume 29, Issue 9, pp. 690 - 691
Host-virus homeostasis is intricately regulated at multiple steps of both interferon (IFN) induction and IFN action; a recent paper by Zhou et al. has revealed... 
PP2A | CELL BIOLOGY | Interferon
Journal Article
15.